
    
      Overweight individuals will be interviewed at baseline and after 30, 60, 90, 120, 150 and 180
      days from baseline. The following measures will be assessed: body composition (fat body% and
      free fat body%), anthropometric measures (height, weight, body mass index, waist
      circumference and abdominal circumference), blood pressure, basal metabolic rate, behavioral
      symptoms, binge eating (binge eating scale) and peripheral biomarkers. Behavioral symptoms
      will be assessed using the following self-reported questionnaires: Beck Depression Inventory
      (depression symptoms), Beck Anxiety Inventory (anxiety symptoms), Medical Outcomes Study 36 -
      Item Short - Form Health Survey (quality of life) and Perceived Stress Scale (stress).

      Enrolled participants will receive restrictive diet calculated on individual requirements
      aiming at the loss from two to four kilogram per month in addition to capsules of ginger or
      placebo, as follows:

        -  Group 1 will receive vials containing 90 capsules of 200mg of dry extract of ginger (5%
           active ingredient) to be taken three times a day for six months in addition to
           restrictive diet.

        -  Group 2 will receive vials containing 90 capsules of 200mg of placebo (cellulose) to be
           taken three times a day for six months in addition to restrictive diet.
    
  